☆ 4.6 Letter

Clinical predictors of COVID-19 severity and bleeding in the ACTIV-4B COVID-19 outpatient thrombosis prevention trial

AMERICAN JOURNAL OF HEMATOLOGY (2022)

Effect of Antithrombotic Therapy on Clinical Outcomes in Outpatients With Clinically Stable Symptomatic COVID-19 The ACTIV-4B Randomized Clinical Trial

Jean M. Connors et al.

Summary: This study aimed to assess the impact of anticoagulant or antiplatelet therapy on symptomatic clinically stable outpatients with COVID-19. The results showed that treatment with aspirin or apixaban compared with placebo did not reduce the rate of a composite clinical outcome, and the study was terminated early due to a lower than anticipated event rate.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2021)

添加到收藏夹

Article Multidisciplinary Sciences

Risk factors for hospitalization among persons with COVID-19-Colorado

Grace M. Vahey et al.

Summary: This study identified risk factors for COVID-19 hospitalization using patient questionnaires and chart abstraction. Factors associated with hospitalization included chronic hypoxemic respiratory failure, taking opioids, metabolic syndrome, obesity, age >= 65 years, hypertension, arrhythmia, and male sex. These findings can help inform clinical and public health resource needs.

PLOS ONE (2021)

添加到收藏夹

Letter Immunology

Obesity in Patients Younger Than 60 Years Is a Risk Factor for COVID-19 Hospital Admission

Jennifer Lighter et al.

CLINICAL INFECTIOUS DISEASES (2020)

添加到收藏夹

Article Medicine, General & Internal

Factors Associated With Death in Critically Ill Patients With Coronavirus Disease 2019 in the US

Shruti Gupta et al.

JAMA INTERNAL MEDICINE (2020)

添加到收藏夹

Article Public, Environmental & Occupational Health

Coronavirus Disease 2019 Case Surveillance - United States, January 22-May 30, 2020

Erin K. Stokes et al.

MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT (2020)

添加到收藏夹

Article Hematology

Prevalence and Outcomes of D-Dimer Elevation in Hospitalized Patients With COVID-19

Jeffrey S. Berger et al.

ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2020)

添加到收藏夹

Article Hematology

Definition of clinically relevant non-major bleeding in studies of anticoagulants in atrial fibrillation and venous thromboembolic disease in non-surgical patients: communication from the SSC of the ISTH

S. Kaatz et al.

JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2015)

添加到收藏夹

Clinical predictors of COVID-19 severity and bleeding in the ACTIV-4B COVID-19 outpatient thrombosis prevention trial

相关参考文献

Effect of Antithrombotic Therapy on Clinical Outcomes in Outpatients With Clinically Stable Symptomatic COVID-19 The ACTIV-4B Randomized Clinical Trial

Risk factors for hospitalization among persons with COVID-19-Colorado

Obesity in Patients Younger Than 60 Years Is a Risk Factor for COVID-19 Hospital Admission

Factors Associated With Death in Critically Ill Patients With Coronavirus Disease 2019 in the US

Coronavirus Disease 2019 Case Surveillance - United States, January 22-May 30, 2020

Prevalence and Outcomes of D-Dimer Elevation in Hospitalized Patients With COVID-19

Definition of clinically relevant non-major bleeding in studies of anticoagulants in atrial fibrillation and venous thromboembolic disease in non-surgical patients: communication from the SSC of the ISTH

导出引文

分享论文